Teligent (TLGT) Shares Down 11.9%

Teligent Inc (NASDAQ:TLGT)’s share price fell 11.9% on Thursday . The stock traded as low as $2.50 and last traded at $2.52. 637,278 shares traded hands during trading, an increase of 22% from the average session volume of 522,154 shares. The stock had previously closed at $2.86.

Several research firms have weighed in on TLGT. ValuEngine upgraded shares of Teligent from a “hold” rating to a “buy” rating in a research report on Friday, November 2nd. Canaccord Genuity set a $4.00 price objective on shares of Teligent and gave the stock a “hold” rating in a research report on Monday, August 13th.

The company has a debt-to-equity ratio of 3.31, a quick ratio of 1.79 and a current ratio of 2.77. The stock has a market capitalization of $165.43 million, a price-to-earnings ratio of -13.26 and a beta of 1.23.

Teligent (NASDAQ:TLGT) last posted its quarterly earnings data on Tuesday, November 13th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). Teligent had a negative net margin of 62.19% and a negative return on equity of 50.85%. The firm had revenue of $18.29 million for the quarter, compared to analysts’ expectations of $19.80 million. As a group, sell-side analysts expect that Teligent Inc will post -0.13 EPS for the current year.

In other news, CEO Jason Grenfell-Gardner sold 52,800 shares of the business’s stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $4.00, for a total transaction of $211,200.00. Following the transaction, the chief executive officer now directly owns 94,949 shares in the company, valued at approximately $379,796. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 22.80% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Bridgeway Capital Management Inc. grew its holdings in shares of Teligent by 112.7% during the 3rd quarter. Bridgeway Capital Management Inc. now owns 283,081 shares of the company’s stock valued at $1,118,000 after acquiring an additional 150,000 shares in the last quarter. Virtu Financial LLC purchased a new position in shares of Teligent during the 3rd quarter valued at $172,000. BlackRock Inc. grew its holdings in shares of Teligent by 0.5% during the 3rd quarter. BlackRock Inc. now owns 3,463,605 shares of the company’s stock valued at $13,681,000 after acquiring an additional 16,198 shares in the last quarter. Wells Fargo & Company MN grew its holdings in shares of Teligent by 15.9% during the 3rd quarter. Wells Fargo & Company MN now owns 123,329 shares of the company’s stock valued at $488,000 after acquiring an additional 16,919 shares in the last quarter. Finally, Northpointe Capital LLC purchased a new position in shares of Teligent during the 3rd quarter valued at $2,948,000. Institutional investors and hedge funds own 69.53% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Teligent (TLGT) Shares Down 11.9%” was originally published by WKRB News and is owned by of WKRB News. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.wkrb13.com/2018/11/16/teligent-tlgt-shares-down-11-9.html.

Teligent Company Profile (NASDAQ:TLGT)

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

Featured Article: Dollar Cost Averaging

Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply